News und Analysen

Fool.com contributor Parkev Tatevosian compares AT&T (NYSE: T) and Broadcom (NASDAQ: AVGO) on dividend yield, operating profit margin, and forward price-to-earnings ratio to answer which stock is

Image source: The Motley Fool.

DexCom (NASDAQ: DXCM)Q2 2023 Earnings CallJul 27, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Biotech stocks are famously volatile, and investors needed to look no further than the performance of Novocure's (NASDAQ: NVCR) shares on Thursday for proof. The company's share price cratered by

Image source: The Motley Fool.

AbbVie (NYSE: ABBV)Q2 2023 Earnings CallJul 27, 2023, 9:00 a.m. ET

Liz Shea

Continue reading

Source Fool.com

Shares of Evolus (NASDAQ: EOLS) were up more than 25% as of 11 a.m. ET after the company reported record quarterly revenue and increased guidance. The stock is up 31% so far this year.

Evolus is a

Even with government programs like Social Security, many people seek to save their own money for retirement, often setting the goal of reaching the $1 million mark by the time they reach retirement

On July 18, Pfizer (NYSE: PFE) announced that it is forging a strategic alliance with Flagship Pioneering, a venture capital (VC) firm, in which the pair would invest $50 million each into 10

Equity markets can be volatile, erratic, and not always entirely rational. That sometimes results in shares of companies not being adequately priced. And when these stocks trade for less than

Since the beginning of 2023, equity markets have been experiencing what could be the start of a bull run. Buying shares of growth stocks is an excellent move for investors looking to ride this wave

Both AT&T (NYSE: T) and Verizon (NYSE: VZ) are dealing with consumers who have become less willing to upgrade their smartphones and more willing to switch wireless providers. For Verizon, this has

When you think about biotech leaders, the name Biogen (NASDAQ: BIIB) may come to mind. Over the years, this biotechnology giant built a powerful multiple sclerosis (MS) treatment platform that has

Telecom stocks are often reliable income investments to own, but investors aren't so sure that's the case with AT&T (NYSE: T). The stock yields 7.6% right now, as its share price has fallen 19% this

If you're shopping for a healthcare stock that promises growth, the medical technology space could offer some good choices. Many suffered at certain points during the earlier days of the pandemic as

Shares of the brain-health specialist Sage Therapeutics (NASDAQ: SAGE) are having a tough trading session today. Specifically, the biotech's stock was down by approximately 13% on heavy volume as of

Image source: The Motley Fool.

AT&T (NYSE: T)Q2 2023 Earnings CallJul 26, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Companies that possess the characteristic of consistency are arguably the foundation upon which all income portfolios should be built. That is because businesses that reliably grow over time can

One thing that can often drive up a stock's value is an increase in guidance. And two companies that recently boosted their projections for the year are Novartis (NYSE: NVS) and PepsiCo (NASDAQ:

There's one main downside to the tremendous performance of the stock market so far in 2023. Many stocks are now priced for perfection. And unfortunately, perfection is rarely attainable.

The good

If you've only recently learned about Invitae (NYSE: NVTA), you can consider yourself lucky. A few years ago, the diagnostics business wowed Wall Street with plans to bring genetic testing to the